![Diantha Duvall](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Diantha Duvall
Finanzdirektor/CFO bei
CURIS, INC.
Vermögen: 3 260 $ am 30.09.2026
Profil
Diantha Duvall is currently Director at BioTheryX, Inc. since 2021 and CFO, Treasurer & Chief Accounting Officer at Curis, Inc. since 2022.
Former positions include Executive Director at Merck & Co., Inc. from 2009 to 2015, Global Commercial Controller at Biogen, Inc. from 2016 to 2017, Chief Accounting Officer, VP & Controller at Bioverativ, Inc. from 2017 to 2019, and Chief Financial Officer at Genocea Biosciences, Inc. from 2019 to 2022.
Education includes undergraduate studies at Colby College and graduate studies including an MBA at Northeastern University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CURIS, INC. 0.19% | 07.07.2026 | 3’885 ( 0.19% ) | 3 260 $ | 30.09.2026 |
Aktive Positionen von Diantha Duvall
| Unternehmen | Position | Beginn |
|---|---|---|
| CURIS, INC. | Finanzdirektor/CFO | 05.08.2022 |
BioTheryX, Inc.
 BioTheryX, Inc. Packaged SoftwareTechnology Services Operates as a biopharmaceutical company that develops protein degradation platform | Direktor/Vorstandsmitglied | 09.08.2021 |
Ehemalige bekannte Positionen von Diantha Duvall
| Unternehmen | Position | Ende |
|---|---|---|
| GENOCEA BIOSCIENCES, INC. | Finanzdirektor/CFO | 01.07.2022 |
| BIOVERATIV INC | Comptroller/Controller/Auditor | 01.01.2019 |
| BIOGEN INC. | Corporate Officer/Principal | 01.01.2017 |
| MERCK & CO., INC. | Direktor/Vorstandsmitglied | 01.01.2015 |
Ausbildung von Diantha Duvall
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
77
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Curis, Inc.
 Curis, Inc. BiotechnologyHealth Technology Develops therapeutics to treat cancer | Health Technology |
Genocea Biosciences, Inc.
 Genocea Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that discovers and develops novel cancer immunotherapies | Health Technology |
BioTheryX, Inc.
BioTheryX, Inc. Packaged SoftwareTechnology Services Operates as a biopharmaceutical company that develops protein degradation platform | Technology Services |
Colby College
 Colby College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bioverativ, Inc.
 Bioverativ, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in discovery, research, development and commercialization of therapies for hemophilia & blood disorders | Health Technology |
